NCT03084562View on ClinicalTrials.gov

Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 3, 2017

Primary Completion Date

October 9, 2017

Study Completion Date

October 9, 2017

Conditions
Myocardial Perfusion Imaging
Interventions
OTHER

collect examination time, functional and clinical tolerability

Examination time : time from patient setup and launch of the pre-test to the end of the patient monitoring Functional tolerability : functional assessed by the patient Clinical tolerability : clinical score by the cardiologist

Trial Locations (1)

69677

Lyon civil Hospital - Est Hospital Complexe - Nuclear Medicine Service, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03084562 - Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT | Biotech Hunter | Biotech Hunter